Trial Profile
A Randomized, Repeated- Dose, Parallel-Group Comparison of Safety, Efficacy, and Quality of Life Measures With Dilaudid CR (Hydromorphone HCI) or Oxycontin (Oxycodone HCI) in Patients With Chronic Osteoarthritis
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 23 Jul 2009
Price :
$35
*
At a glance
- Drugs Hydromorphone (Primary) ; Oxycodone
- Indications Musculoskeletal pain; Osteoarthritis
- Focus Therapeutic Use
- Sponsors ALZA Corporation
- 12 Dec 2006 New trial record.